CO could also target sGC and regulate NO-mediated vasodilatation [88], which was supported by a report showing that transgenic mice overexpressing cell-specific HO-1 exhibit hypertension coinciding with decreased cGMP production in response to NO [89]. This evidence concerns the gene HMOX1 and hypertensive disorder.